Chemoinformaics analysis of Caffeoyl-Feruloyl-Spermidine
| Molecular Weight | 483.565 | nRot | 13 |
| Heavy Atom Molecular Weight | 450.301 | nRig | 16 |
| Exact Molecular Weight | 483.237 | nRing | 2 |
| Solubility: LogS | -2.615 | nHRing | 0 |
| Solubility: LogP | 1.479 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 68 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 33 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 73.5362 |
| nHD | 5 | BPOL | 38.2878 |
| QED | 0.166 |
| Synth | 2.854 |
| Natural Product Likeliness | 0.4 |
| NR-PPAR-gamma | 0.101 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.993 |
| HIA | 0.963 |
| CACO-2 | -5.97 |
| MDCK | 0.0000042 |
| BBB | 0.007 |
| PPB | 0.720019 |
| VDSS | 1.584 |
| FU | 0.279669 |
| CYP1A2-inh | 0.159 |
| CYP1A2-sub | 0.451 |
| CYP2c19-inh | 0.039 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.03 |
| CYP2c9-sub | 0.202 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.864 |
| CYP3a4-inh | 0.05 |
| CYP3a4-sub | 0.224 |
| CL | 14.61 |
| T12 | 0.918 |
| hERG | 0.426 |
| Ames | 0.066 |
| ROA | 0.451 |
| SkinSen | 0.969 |
| Carcinogencity | 0.041 |
| EI | 0.013 |
| Respiratory | 0.888 |
| NR-Aromatase | 0.836 |
| Antiviral | Yes |
| Prediction | 0.873781 |